Veterinary Dermatology Market

The report "Veterinary Dermatology Market by Route of Administration, Product type (Antibacterial, Antifungal, Antiparasitic Drugs, Monoclonal Antibodies), Condition type (Parasitic Infections, Infectious Diseases, Skin Cancer), Animal type - Global Forecast to 2030", global veterinary dermatology market is expected to reach USD 30.31 billion by 2030 from USD 20.11 billion in 2025, at a CAGR of 8.5%, during the forecast period.

Browse 340 market data Tables and 84 Figures spread through 384 Pages and in-depth TOC on "Veterinary Dermatology Market by Route of Administration, Product type (Antibacterial, Antifungal, Antiparasitic Drugs, Monoclonal Antibodies), Condition type (Parasitic Infections, Infectious Diseases, Skin Cancer), Animal type - Global Forecast to 2030"
View detailed Table of Content here - https://www.marketsandmarkets.com/Market-Reports/animal-dermatology-market-195447184.html

The Veterinary Dermatology Market is growing steadily with increased rates of skin diseases in animals and growing pet ownership. General dermatological conditions like atopic dermatitis, parasitic diseases like mange and flea allergy dermatitis, pyoderma, fungal diseases like ringworm, and autoimmune skin disease are common among companion and livestock animals. The market includes a variety of products, e.g., topical therapy like shampoos, sprays, and creams, systemic treatment like antibiotics, antifungals, and corticosteroids, and biologics like monoclonal antibodies and immunotherapy. Dogs, cats, horses, and cattle are the major affected species. Advances in technology, such as new biologic therapeutics, enhanced diagnostics, and teledermatology, are improving outcomes. Growing awareness, pet insurance protection, and R&D expenditure are also driving the market landscape, driving innovation and increasing treatment choices.

"Based on route of administration, topical segment accounted for the largest share in the maket in 2024."

Based on Route of Administration, the market is divided into Topical, Injectables and Oral. The Topical segment accounted for the largest market share in 2024 and is expected to further grow at the highest CAGR. Topical segment include creams, ointments, and shampoos to treat skin infections, allergies, and ectoparasitic infestations, and they are commonly used because of their ease of application. This trend is further being driven by the increasing interest in non-invasive treatments.

"By product type, the antiparasitic drugs segment is expected to grow at the fastest CAGR in the market during the forecast period."

The market consists of Antiparasitic Drugs, Antifungal Drugs, Antibacterial Drugs, Monoclonal Antibodies, and Other Product Types, by Product Type. The Antiparasitic Drugs segment is expected to grow at the highest CAGR during 2025 to 2030. These types of products are important for the treatment of external parasites like fleas, ticks, and mites, which are common in animals especially pets. The increasing prevalence of parasitic infestations in pets and livestock, along with advancements in antiparasitic formulations, is fueling the expansion of this segment globally.

"By condition type, parasitic infections segment accounted for the largest share of the global veterinary dermatology market."

By Condition Type, the market is divided into categories like Parasitic Infection, Infectious Diseases, Autoimmune Diseases, Skin Cancer, and Other Condition Types. Parasitic Infection segment held the largest market share in 2024. Conditions caused by mites, fleas, and ticks are widespread among companion and livestock animals, raising concerns for effective treatment options. The growing awareness about animal health and the availability of advanced diagnostic techniques contribute to the increasing demand for veterinary dermatology products addressing parasitic infections.

"By animal type, companion animal segment is expected to grow at the fastest rate in the global veterinary dermatology market during the forecast period."

By Animal Type, the market is divided into Companion Animals and Livestock Animals. The Companion Animals segment is projected to witness the fastest growth rate. Rising pet adoption, increased spending on pet health, and growing concerns about skin conditions in dogs and cats are the major driving factors of this segment. Additionally, the demand for advanced dermatology treatments, including prescription medicines and specialized skincare products, is rising among pet owners worldwide.

“By end users, veterinary hospitals and clinics end-user segment held the largest market share in the market.”

By End User, the market is categorized into Veterinary Hospitals & Clinics, Animal Shelters & Rescues, and Other End Users. Veterinary Hospitals & Clinics accounted for the largest market share in the Veterinary Dermatology Market. These facilities provide specialized care, including dermatological treatments, diagnostic services, and advanced therapies. The increasing number of veterinary clinics and hospitals, and veterinary practioners along with growing investments in animal healthcare infrastructure, is boosting the dominance of this segment.

“By region, APAC will grow at the fastest growth rate durning the forecast period.”

The region’s rapid market expansion is attributed to the rising pet population, increasing awareness about animal skin diseases, and growing expenditure on veterinary care. Additionally, improving veterinary healthcare infrastructure and the presence of key market players are further driving growth in countries like China, India, and Japan. Livestock farming also plays a significant role in the region's economy. Countries like India and China have large number of livestock animals, driven by the rising demand for meat, milk, and other animal-based products.

Key Market Players

Prominent players in the veterinary dermatology market are Elanco Animal Health Incorporated (US), Merck & Co., Inc. (US), Virbac (France), Zoetis Inc. (US), Boehringer Ingelheim International GmbH (Germany), Vetoquinol (France), Dechra Pharmaceuticals plc (UK), Hester Biosciences Limited (India), PetIQ, Inc. (US), Ourofino Saude Animal (Brazil), Swedencare (Sweden), Orion Corporation (Finland), Norbrook (Ireland), Ceva Sante Animale (France), Bimeda, Inc. (Ireland), Indian Immunologicals Ltd. (India), Vetanco (Brazil), Chanelle Pharma (Ireland), Pegasus Laboratories, Inc. (US), Nutramax Laboratories, Inc. (US), AVet Health (Australia), Animalderma Srls (Italy), LETI Pharma (Spain), Huvepharma, Inc. (Bulgaria), and VetPlus (UK).

Don’t miss out on business opportunities in Veterinary Dermatology Market. Speak to our analyst and gain crucial industry insights that will help your business grow.

About MarketsandMarkets™

MarketsandMarkets™ provides quantified B2B research on 30,000 high growth niche opportunities/threats which will impact 70% to 80% of worldwide companies’ revenues. Currently servicing 7500 customers worldwide including 80% of global Fortune 1000 companies as clients. Almost 75,000 top officers across eight industries worldwide approach MarketsandMarkets™ for their painpoints around revenues decisions.

Our 850 fulltime analyst and SMEs at MarketsandMarkets™ are tracking global high growth markets following the "Growth Engagement Model – GEM". The GEM aims at proactive collaboration with the clients to identify new opportunities, identify most important customers, write "Attack, avoid and defend" strategies, identify sources of incremental revenues for both the company and its competitors. MarketsandMarkets™ now coming up with 1,500 MicroQuadrants (Positioning top players across leaders, emerging companies, innovators, strategic players) annually in high growth emerging segments. MarketsandMarkets™ is determined to benefit more than 10,000 companies this year for their revenue planning and help them take their innovations/disruptions early to the market by providing them research ahead of the curve.

MarketsandMarkets’s flagship competitive intelligence and market research platform, "Knowledgestore" connects over 200,000 markets and entire value chains for deeper understanding of the unmet insights along with market sizing and forecasts of niche markets.

Contact:
Mr. Rohan Salgarkar
MarketsandMarkets™ INC.
1615 South Congress Ave.
Suite 103, Delray Beach, FL 33445
USA : 1-888-600-6441
sales@marketsandmarkets.com